ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
98,262.12
0.05%
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs Yen
157.205
0.00%
Brent Oil
76.495
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) ニュース

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VTYX
日付受信時刻ニュースソース見出しコード企業名
2025/01/0408 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2025/01/0408 : 54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2025/01/0408 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2025/01/0408 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/3107 : 33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/2806 : 46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/2008 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/2008 : 49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/2008 : 48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/12/1207 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/11/2611 : 07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/11/1814 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VTYXVentyx Biosciences Inc
2024/11/1606 : 59Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VTYXVentyx Biosciences Inc
2024/11/0807 : 13Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VTYXVentyx Biosciences Inc
2024/11/0806 : 58Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
2024/11/0806 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
2024/11/0806 : 05GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
2024/10/1521 : 00GlobeNewswire Inc.Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024NASDAQ:VTYXVentyx Biosciences Inc
2024/10/0105 : 40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VTYXVentyx Biosciences Inc
2024/09/2321 : 18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
2024/09/2321 : 00GlobeNewswire Inc.Ventyx Biosciences Announces $27 Million Strategic Investment from SanofiNASDAQ:VTYXVentyx Biosciences Inc
2024/09/1005 : 47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/09/0621 : 00GlobeNewswire Inc.Ventyx Biosciences Announces Initiation of Dosing in a Phase 2a Trial of VTX3232 in Patients with Early Parkinson’s DiseaseNASDAQ:VTYXVentyx Biosciences Inc
2024/08/3021 : 15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
2024/08/3021 : 00GlobeNewswire Inc.Ventyx Biosciences Announces Departure of Chief Financial OfficerNASDAQ:VTYXVentyx Biosciences Inc
2024/08/2821 : 00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
2024/08/1405 : 48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/08/1405 : 35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
2024/08/0905 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
2024/08/0905 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:VTYX

最近閲覧した銘柄

NYSE
AXP
American Express
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
FX
USDEUR
US Dollar vs Euro
NYSE
KO
Coca Cola
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
USOTC
BASFY
BASF (QX)
CCOM
US100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
COIN
AVAXUSD
Avalanche
COIN
ETHUSD
Ethereum
NYSE
CVX
Chevron
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有